PROM1 and neoplasm: Both in vitro and in vivo tumor xenograft assays show that the expression of CD133, known as a GSC marker, is associated with increased neutrophil recruitment and IL-1β signaling, underlining the crosstalk between GSCs and neutrophils [178].